Sermorelin Research Guide: GHRH Analogue and Pituitary GH Stimulation

Overview

Sermorelin (GRF 1-29 NH2) is a synthetic analogue of endogenous growth hormone releasing hormone (GHRH), comprising the first 29 amino acids of the native 44-amino acid peptide — the shortest fragment that retains full GHRH receptor binding and biological activity. By stimulating pituitary somatotrophs directly via the GHRH receptor, Sermorelin promotes physiological GH secretion rather than exogenous GH administration, making it a valuable tool in research exploring the hypothalamic-pituitary-somatotropic axis. FenaLife supplies Sermorelin for laboratory research use only.

Research Background

Sermorelin was FDA-approved in 1997 for diagnosis and treatment of idiopathic GH deficiency in children (as Geref). Research interest expanded into adult somatopause applications, with studies focusing on body composition, sleep quality, bone density, and metabolic parameters. Unlike CJC-1295 (which incorporates the Drug Affinity Complex to extend half-life to days), Sermorelin has a short half-life of 10-20 minutes, producing physiological GH pulses that mirror the body’s natural ultradian secretion rhythm — a distinction relevant to research designs studying pulsatile versus sustained GH exposure.

Studied Mechanisms

Sermorelin binds the GHRH receptor (GHRHR) on anterior pituitary somatotrophs, activating adenylyl cyclase via Gs protein coupling. The resulting cAMP elevation triggers GH synthesis and secretion. Sermorelin also stimulates GHRHR gene expression over time, potentially enhancing pituitary responsiveness. Its short half-life ensures GH release remains pulsatile and self-limiting, preserving the natural feedback architecture of the GH axis and avoiding the receptor desensitization associated with continuous GH stimulation.

Molecular Profile

Type: Synthetic peptide (GHRH 1-29 analogue). Molecular weight: ~3357.9 Da. Half-life: 10-20 minutes. Also known as: GRF 1-29, Geref. Purity: ≥98% by HPLC.

Storage and Handling

Store lyophilized Sermorelin at -20°C, protected from light. Reconstitute with bacteriostatic water. Due to susceptibility to degradation in solution, use reconstituted Sermorelin within 2 to 4 weeks stored at 4°C. Avoid repeated freeze-thaw cycles.

Research Use Only

For laboratory research purposes only. Not for human or veterinary use. Certificate of Analysis available per batch.